Overactive bladder is a medical condition with active clinical research programs worldwide.

29 total trials for this combination

Showing top 10 of 29 trials

Trials

NCT ID	Title	Status	Phase
NCT06511141	Sacral Neuromodulation for Male Overactive Bladder (MOAB)	RECRUITING	—
NCT02660138	Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1	TERMINATED	PHASE3
NCT01972841	This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder	COMPLETED	PHASE3
NCT01302067	A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine	COMPLETED	PHASE4
NCT00911937	A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency	COMPLETED	PHASE4
NCT03902080	Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)	COMPLETED	PHASE3
NCT00536484	Fesoterodine Flexible Dose Study	COMPLETED	PHASE3
NCT03492281	A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB)	COMPLETED	PHASE3
NCT02045862	A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder	COMPLETED	PHASE3
NCT00444925	Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)	COMPLETED	PHASE3

Related Pages

All Overactive bladder trials All trials in Houston, United States